FrontierLab
A research filter, not a predictor — not financial advice. Grades rank growth stocks on evidence-based quality signals from end-of-day data; they are not buy/sell calls or price forecasts. Always do your own research.

Integra LifeSciences Holdings Corporation IART

Mixed   broader-coverage candidate · Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments.

On FrontierLab's discovery record since 2026-09-09 (3 weeks ago) — when this name first surfaced. (distinct from the snapshot date below)

Auto-graded broader coverage — sourced by an automated screen and graded on default bands, not the sector-calibrated bands the curated screener uses. A "Mixed" here is NOT the same bar as a curated grade; these are auto-screened candidates for your own research, shown as of their surface date (2026-09-10), not the curated Frontier signal.

Key quality signals

Revenue growth (YoY)1.6%
Gross margin53.7%
Gross profits / assets0.25
Rule of 4041.4
Net margin39.8%
Cash runway (months)—
PEG—
Price / sales0.8

Quality checklist

Fundamentals — snapshot as of 2026-09-10

StageEstablished
Share issuance (YoY)2.2% · modest issuance
Moat—
TAM—
P/E (trailing)—
EPS (trailing)$-0.09
Burn multiple—
Gross-margin trend (pts)1.1
Cash / assets0.08
Net debt / EBITDA7.3
Statements as ofQ2 FY2026 · filed 2026-07-29

Momentum context — a snapshot from 2026-09-10, not current

Price at surface$16.25 (as of 2026-09-10)
52-week range$8.7 – $20.49
% off 52-wk high-20.7%
RSI (14)39
Relative volume1×

← All broader-coverage names · Curated names → · Open the interactive screener →

Data as of 2026-09-10 (end-of-day). How grades are computed →